Leaflet: information for the user
Ramipril Alter Generics 1.25 mg tablets EFG
Ramipril Alter Generics 2.5 mg tablets EFG
Ramipril Alter Generics 5 mg tablets EFG
Ramipril Alter Generics 10 mg tablets EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you.
6. Contents of the pack and additional information
Ramipril Alter Genéricos contains a medication called ramipril. This belongs to a group of medications called angiotensin-converting enzyme (ACE) inhibitors.
Ramipril works as follows:
Ramipril may be used:
Do not take Ramipril Alter Genéricos
The symptoms of an allergic reaction may include skin rash, difficulty swallowing or breathing, swelling of your lips, face, throat, or tongue.
- an angiotensin II receptor antagonist (ARA) (also known as “sartanes” - for example, valsartán, telmisartán, irbesartán), particularly if you have kidney problems related to diabetes.
- aliskirén.
Your doctor may monitor your renal function, blood pressure, and electrolyte levels in your blood (such as potassium) at regular intervals. See also the information under the heading “Do not take Ramipril Alter Genéricos”.
Children and adolescents
The use of ramipril in children and adolescents under 18 years is not recommended because the safety and efficacy of ramipril in children have not been established.
If any of the above conditions apply (or you are unsure), speak with your doctor before taking ramipril.
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. This is because ramipril may affect how other medications work. Similarly, some medications may affect how ramipril works.
Inform your doctor if you have taken or are taking any of the following medications, which may make ramipril less effective:
Inform your doctor if you are taking any of the following medications. These may increase the risk of side effects if taken with ramipril:
Inform your doctor if you are taking any of the following medications. These may be affected by ramipril:
If any of the above conditions apply (or you are unsure), speak with your doctor before taking ramipril.
Taking Ramipril Alter Genéricos with food, drinks, and alcohol
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant (or suspect you may be).
You should not take ramipril during the first 12 weeks of pregnancy and should not take it at all from week 13, as its use during pregnancy may cause harm to your baby. If you become pregnant while taking ramipril, inform your doctor immediately. A suitable alternative treatment should be changed before planning a pregnancy.
Breastfeeding
You should not take ramipril if you are breastfeeding.
Consult your doctor or pharmacist before using any medication.
You may feel dizzy while taking ramipril, which is more likely to occur when you start taking ramipril or when you start taking a higher dose of ramipril. If this happens, do not drive or operate tools or machinery.
Ramipril Alter Genéricos contains sodium
This medication contains less than 23 mg of sodium (1mmol) per tablet; it is essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor. Consult your doctor or pharmacist if you have doubts.
Medication intake
How much medication to take
Hypertension treatment
To reduce the risk of suffering a heart attack or stroke
Kidney disease treatment to reduce or delay worsening
Heart failure treatment
Treatment after a heart attack
Older patients
Your doctor will reduce the initial dose and adjust your treatment more slowly.
If you take more Ramipril Alter Genéricos than you should
Consult your doctor immediately or go to the nearest hospital emergency room. Do not drive to the hospital, ask someone to take you or call an ambulance. Bring the medication packaging with you. This way, your doctor will know what you have taken.
You can also call the Toxicology Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to take Ramipril Alter Genéricos
If you interrupt treatment with Ramipril Alter Genéricos
Continue taking this medication until your doctor tells you to stop. Do not stop taking this medication just because you feel better. If you do, your condition may return.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking ramipril and seek immediate medical attention if you notice any of the following severe side effects, as you may need urgent medical treatment:
Inform your doctor immediately if you experience:
Other side effects include:
Inform your doctor if any of the following worsen or last more than a few days.
Frequent(can affect up to 1 in 10 patients)
Infrequent(can affect up to 1 in 100 patients)
Rare(can affect up to 1 in 1,000 patients)
Very rare (can affect up to 1 in 10,000 patients)
Other side effects reported:
Inform your doctor if any of the following worsen or last more than a few days.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it's a possible side effect that doesn't appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de medicamentos de Uso Humano:www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Store in the original packaging to protect it from moisture.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Ramipril Alter Generics
The active ingredient is ramipril. Each tablet contains 1.25 mg; 2.5 mg; 5 mg or 10 mg of ramipril.
The other components are: hypromellose 6cP, microcrystalline cellulose, pregelatinized cornstarch, sodium stearate fumarate, yellow iron oxide (E172): only in 2.5 mg tablets and red iron oxide (E172): only in 5 mg tablets.
Appearance of the product and contents of the package
1.25 mg tablets: biconvex, round, white to almost white tablets, with beveled edges, engraved with the mark 1.25 on one face of the tablet. Tablet diameter: 6.5 mm.
2.5 mg tablets: yellowish light brown tablets, capsule-shaped, with beveled edges and scored on both faces. On one side of the tablet, in the middle, the mark 2.5 is engraved, and on the other half of the tablet the mark KRK is engraved. Tablet dimensions: 8 x 5 mm. The tablet can be divided into equal doses.
5 mg tablets: light pink tablets with individual lighter and darker points, capsule-shaped tablets with beveled edges, scored on both faces. On one side of the tablet, in the middle, the mark 5 is engraved, and on the other half of the tablet the mark KRK is engraved. Tablet dimensions: 8 x 5 mm. The tablet can be divided into equal doses.
10 mg tablets: capsule-shaped tablets, white to almost white, with beveled edges and scored on both faces. On one side of the tablet, in the middle, the mark 10 is engraved, and on the other half of the tablet the mark KRK is engraved. Tablet dimensions: 8 x 5 mm. The tablet can be divided into equal doses.
Ramipril Alter Generics are presented in blisters of 14, 28, 30, 56 or 90 tablets.
Only some package sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
The marketing authorization holder is:
Alter Laboratories, S.A.
C/ Mateo Inurria 30
28036 Madrid
Spain
The responsible manufacturer is:
Krka d.d. Novo Mesto
Šmarješka Cesta 6
Novo Mesto, Southeastern Slovenia, 8501
Slovenia
This medicine is authorized in the member states of the European Economic Area with the following names:
Portugal:Ramipril Ripzen
France: Ramipril Alter
Italy: Ramipril Alter
Spain: Ramipril Alter Generics EFG
Last review date of this leaflet:April 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/.
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.